Zacks Research upgraded shares of Neogen (NASDAQ:NEOG – Free Report) from a strong sell rating to a hold rating in a research note released on Wednesday morning,Zacks.com reports. Zacks Research also issued estimates for Neogen’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at $0.08 EPS, Q3 2026 earnings at $0.08 EPS, Q4 2026 earnings at $0.08 EPS, FY2026 earnings at $0.30 EPS, Q1 2027 earnings at $0.08 EPS, Q2 2027 earnings at $0.09 EPS, Q4 2027 earnings at $0.09 EPS, FY2027 earnings at $0.36 EPS and FY2028 earnings at $0.35 EPS.
Several other analysts also recently issued reports on NEOG. Guggenheim reduced their price target on Neogen from $13.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, June 30th. Piper Sandler dropped their target price on Neogen from $6.40 to $5.00 and set a “neutral” rating for the company in a report on Tuesday, April 22nd. Finally, William Blair downgraded shares of Neogen from an “outperform” rating to a “market perform” rating in a research note on Tuesday, July 29th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $7.50.
Check Out Our Latest Research Report on Neogen
Neogen Trading Up 0.7%
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the stock. CHICAGO TRUST Co NA raised its stake in Neogen by 19.1% in the first quarter. CHICAGO TRUST Co NA now owns 12,498 shares of the company’s stock valued at $108,000 after purchasing an additional 2,000 shares in the last quarter. Ascent Group LLC increased its holdings in Neogen by 17.8% in the 4th quarter. Ascent Group LLC now owns 14,340 shares of the company’s stock valued at $174,000 after buying an additional 2,165 shares during the period. California State Teachers Retirement System increased its holdings in Neogen by 1.1% in the 2nd quarter. California State Teachers Retirement System now owns 191,084 shares of the company’s stock valued at $913,000 after buying an additional 2,166 shares during the period. Avanza Fonder AB raised its position in shares of Neogen by 17.9% in the 2nd quarter. Avanza Fonder AB now owns 16,435 shares of the company’s stock valued at $79,000 after buying an additional 2,499 shares in the last quarter. Finally, Yousif Capital Management LLC lifted its holdings in shares of Neogen by 3.9% during the 1st quarter. Yousif Capital Management LLC now owns 74,508 shares of the company’s stock worth $646,000 after acquiring an additional 2,769 shares during the period. Institutional investors own 96.73% of the company’s stock.
Neogen Company Profile
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Featured Articles
- Five stocks we like better than Neogen
- Using the MarketBeat Dividend Yield Calculator
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- Retail Stocks Investing, Explained
- Alphabet’s Breakout Potential: From Laggard to AI Leader
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- TJX Stock Price Hits Fresh High, Signals More Highs to Follow
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.